Search results for PEX19 antibody

PEX19 antibody, Genetex, GTX32780

PEX19 antibody, Genetex, GTX110721

PEX19 antibody, Genetex, GTX114959

Anti-PEX19 antibody, Abcam, AB95959

PEX19 antibody [GT554], Genetex, GTX628212

PEX19 antibody [GT533], Genetex, GTX628892

PEX19 Antibody (YA2888), MedChemexpress, HY-P83143

PEX19 Antibody (YA2888) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PEX19.

Anti-PEX19 Antibody (R1V76), AntibodySystem, RHE27901

Anti-PEX19 antibody [EPR9266(B)], Abcam, AB137072

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Peroxisomal Biogenesis Factor 19 (PEX19) Antibody, Abbexa, abx004196

PEX19 Antibody is a Rabbit Polyclonal antibody against PEX19. This gene is necessary for early peroxisomal biogenesis. It acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. These disorders have at least 14 complementation groups, with more than one phenotype being observed for some complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of Zellweger syndrome (ZWS), as well as peroxisome biogenesis disorder complementation group 14 (PBD-CG14), which is also known as PBD-CGJ. Alternative splicing results in multiple transcript variants.